Allarity Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $6 |
Gross Profit | -12 | -11 | -1 | |
EBITDA | -2,749 | -2,296 | -2,664 | -7,377 |
EBIT | -2,308 | -2,675 | -7,378 | |
Net Income | -2,806 | -2,320 | -2,732 | -7,453 |
Net Change In Cash | 0 | 0 | 0 | 6 |
Free Cash Flow | -3,410 | -5,481 | -2,686 | -3,504 |
Cash | 16,895 | 17,801 | 25,201 | 19,533 |
Basic Shares | 14,739 | 15,543 | 1,114 | 1,575 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -9 | -37 | -120 | -106 |
EBITDA | -24,234 | -11,283 | -17,296 | -25,769 |
EBIT | -24,243 | -11,320 | -17,356 | -25,875 |
Net Income | -24,515 | -11,901 | -16,058 | -26,648 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -17,337 | |||
Free Cash Flow | -17,650 | -12,745 | -16,835 | -15,050 |
Cash | 19,533 | 166 | 2,029 | 19,555 |
Basic Shares | 1,606 | 3 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.19 |
2025-06-30 | -$0.15 |
2025-03-31 | -$0.25 |
2024-12-31 | -$1.72 |
